RESEARCH, DEVELOPMENT, AND CLINICAL TRIAL EXPENSES, NET (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | |
|---|---|---|---|
Aug. 25, 2025 |
Apr. 30, 2026 |
Apr. 30, 2026 |
|
| ResearchAndDevelopmentLineItems [Line Items] | |||
| Grant received from NCI | $ 110,205 | $ 936,363 | |
| Additional grants receivable | $ 1,100,000 | $ 1,100,000 | |
| National Cancer Institute [Member] | |||
| ResearchAndDevelopmentLineItems [Line Items] | |||
| Grant received from NCI | $ 2,000,000.0 |